Without the ability to create wealth for their companies, pharmaceutical research and development will fall behind and consumers bear the burden. Some reports indicate that the tax on pharma companies may have led to the rising cost of brand name drugs.
This is an alarming thought, considering what they’ve achieved with the right funding.
Consider the fact that not long ago an HIV Positive diagnosis meant death rather than treatment. The creation of antiretroviral drugs and treatment revolutionized the lives of the afflicted. Anti-depressants and anti-anxiety medications have saved lives. Anti-psychotics have helped the mentally ill live productive lives.
There’s a long list of drugs, innovations which revolutionized the lives of millions around the globe thanks to American pharmaceutical research. This era of research is at an end thanks to a lack of funding and the complex regulatory processes which hold it back.
The lack of innovation and the ‘free healthcare for all’ agenda actively damages the free market which should exist and encourage competition between medical companies. After all, more competition equals a more refined, higher quality product reaching consumers.
